Skip to main content
Erschienen in: Journal of General Internal Medicine 12/2012

01.12.2012 | Original Research

Levels and Variation in Overuse of Fecal Occult Blood Testing in the Veterans Health Administration

verfasst von: Melissa R. Partin, PhD, Adam A. Powell, PhD, Ann Bangerter, BS, Krysten Halek, MA, James F. Burgess Jr, PhD, Deborah A. Fisher, MD, David B. Nelson, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

Policy-makers have called for efforts to reduce overuse of cancer screening tests, including colorectal cancer screening (CRCS). Overuse of CRCS tests other than colonoscopy has not been well documented.

OBJECTIVE

To estimate levels and correlates of fecal occult blood test (FOBT) overuse in a national Veterans Health Administration (VHA) sample.

DESIGN

Observational

PARTICIPANTS

Participants included 1,844 CRCS-eligible patients who responded to a 2007 CRCS survey conducted in 24 VHA facilities and had one or more FOBTs between 2003 and 2009.

MAIN MEASURES

We combined survey data on race, education, and income with administrative data on region, age, gender, CRCS procedures, and outpatient visits to estimate overuse levels and variation. We coded FOBTs as overused if they were conducted <10 months after prior FOBT, <9.5 years after prior colonoscopy, or <4.5 years after prior barium enema. We used multinomial logistic regression models to examine variation in overuse by reason (sooner than recommended after prior FOBT; sooner than recommended after colonoscopy, barium enema, or a combination of procedures), adjusting for clustering of procedures within patients, and patients within facilities.

KEY RESULTS

Of 4,236 FOBTs received by participants, 885 (21 %) met overuse criteria, with 323 (8 %) sooner than recommended after FOBT, and 562 (13 %) sooner than recommended after other procedures. FOBT overuse varied across facilities (9–32 %, p < 0.0001) and region (12–23 %, p < .0012). FOBT overuse after prior FOBT declined between 2003 and 2009 (8 %–5 %, p = .0492), but overuse after other procedures increased (11–19 %, p = .0002). FOBT overuse of both types increased with number of outpatient visits (OR 1.15, p < 0.001), but did not vary by patient demographics. More than 11 % of overused FOBTs were followed by colonoscopy within 12 months.

CONCLUSIONS

Many FOBTs are performed sooner than recommended in the VHA. Variation in overuse by facility, region, and outpatient visits suggests addressing FOBT overuse will require system-level solutions.
Literatur
1.
Zurück zum Zitat Welch HG, Frankel BA. Likelihood that a woman with screen-detected breast cancer has had her “life saved” by that screening. Arch Intern Med. 2011;171(22):2043–6.PubMedCrossRef Welch HG, Frankel BA. Likelihood that a woman with screen-detected breast cancer has had her “life saved” by that screening. Arch Intern Med. 2011;171(22):2043–6.PubMedCrossRef
2.
Zurück zum Zitat Fisher DA, Judd L, Sanford NS. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol. 2005;100(11):2526–30.PubMedCrossRef Fisher DA, Judd L, Sanford NS. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol. 2005;100(11):2526–30.PubMedCrossRef
3.
Zurück zum Zitat Meissner HI, Tiro JA, Haggstrom D, Lu-Yao G, Breen N. Does patient health and hysterectomy status influence cervical cancer screening in older women? J Gen Intern Med. 2008;23(11):1822–8.PubMedCrossRef Meissner HI, Tiro JA, Haggstrom D, Lu-Yao G, Breen N. Does patient health and hysterectomy status influence cervical cancer screening in older women? J Gen Intern Med. 2008;23(11):1822–8.PubMedCrossRef
4.
Zurück zum Zitat Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA. 2004;291(24):2990–3.PubMedCrossRef Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA. 2004;291(24):2990–3.PubMedCrossRef
5.
Zurück zum Zitat Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA. 2004;291(20):2466–70.PubMedCrossRef Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA. 2004;291(20):2466–70.PubMedCrossRef
6.
Zurück zum Zitat Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336–42.PubMedCrossRef Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336–42.PubMedCrossRef
7.
Zurück zum Zitat Walter LC, Lindquist K, Nugent S, Schult T, Lee SJ, Casadei MA, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465–73.PubMed Walter LC, Lindquist K, Nugent S, Schult T, Lee SJ, Casadei MA, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465–73.PubMed
8.
Zurück zum Zitat Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. JAMA. 2010;304(14):1584–91.PubMedCrossRef Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. JAMA. 2010;304(14):1584–91.PubMedCrossRef
9.
Zurück zum Zitat US Preventive Services Task Force. Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2008;149(9):627–37. US Preventive Services Task Force. Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2008;149(9):627–37.
10.
Zurück zum Zitat Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570–95.PubMedCrossRef Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570–95.PubMedCrossRef
11.
Zurück zum Zitat Richardson LC, Tai E, Rim SH, Joseph D, Plescia M. Vital signs: colorectal cancer screening, incidence, and mortality–United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;60(26):884–9. Richardson LC, Tai E, Rim SH, Joseph D, Plescia M. Vital signs: colorectal cancer screening, incidence, and mortality–United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;60(26):884–9.
14.
Zurück zum Zitat Steinwachs D, Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, et al. NIH state-of-the-science conference statement on enhancing use and quality of colorectal cancer screening. NIH. 2010;27(1):1–31. Steinwachs D, Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, et al. NIH state-of-the-science conference statement on enhancing use and quality of colorectal cancer screening. NIH. 2010;27(1):1–31.
15.
16.
Zurück zum Zitat Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145(12):880–6.PubMed Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145(12):880–6.PubMed
17.
Zurück zum Zitat Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150(12):849–57. W152.PubMed Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150(12):849–57. W152.PubMed
18.
Zurück zum Zitat Kahi CJ, van Ryn M, Juliar B, Stuart JS, Imperiale TF. Provider recommendations for colorectal cancer screening in elderly veterans. J Gen Intern Med. 2009;24(12):1263–8.PubMedCrossRef Kahi CJ, van Ryn M, Juliar B, Stuart JS, Imperiale TF. Provider recommendations for colorectal cancer screening in elderly veterans. J Gen Intern Med. 2009;24(12):1263–8.PubMedCrossRef
19.
Zurück zum Zitat Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the medicare population. Arch Intern Med. 2011;171(15):1335–43.PubMedCrossRef Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the medicare population. Arch Intern Med. 2011;171(15):1335–43.PubMedCrossRef
20.
Zurück zum Zitat Krist AH, Jones RM, Woolf SH, Woessner SE, Merenstein D, Kerns JW, et al. Timing of repeat colonoscopy: disparity between guidelines and endoscopists’ recommendation. Am J Prev Med. 2007;33(6):471–8.PubMedCrossRef Krist AH, Jones RM, Woolf SH, Woessner SE, Merenstein D, Kerns JW, et al. Timing of repeat colonoscopy: disparity between guidelines and endoscopists’ recommendation. Am J Prev Med. 2007;33(6):471–8.PubMedCrossRef
21.
Zurück zum Zitat Yabroff KR, Klabunde CN, Yuan G, McNeel TS, Brown ML, Casciotti D, et al. Are physicians’ recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2010;26(2):177–84.PubMedCrossRef Yabroff KR, Klabunde CN, Yuan G, McNeel TS, Brown ML, Casciotti D, et al. Are physicians’ recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2010;26(2):177–84.PubMedCrossRef
22.
Zurück zum Zitat Hoff G, Dominitz JA. Contrasting US and European approaches to colorectal cancer screening: which is best? Gut. 2010;59(3):407–14.PubMedCrossRef Hoff G, Dominitz JA. Contrasting US and European approaches to colorectal cancer screening: which is best? Gut. 2010;59(3):407–14.PubMedCrossRef
23.
Zurück zum Zitat The Multicentre Australian Colorectal-neoplasia Screening Group (MACS). A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust. 2006;184(11):546–50. The Multicentre Australian Colorectal-neoplasia Screening Group (MACS). A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust. 2006;184(11):546–50.
24.
Zurück zum Zitat Kanavos P, Schurer W. The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ. 2010;10(Suppl 1):S115–29.PubMedCrossRef Kanavos P, Schurer W. The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ. 2010;10(Suppl 1):S115–29.PubMedCrossRef
25.
Zurück zum Zitat Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008;122(6):1357–67.PubMedCrossRef Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008;122(6):1357–67.PubMedCrossRef
26.
Zurück zum Zitat Partin MR, Noorbaloochi S, Grill J, Burgess DJ, van Ryn M, Fisher DA, et al. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence. Cancer Causes Control. 2010;21(9):1357–68.PubMedCrossRef Partin MR, Noorbaloochi S, Grill J, Burgess DJ, van Ryn M, Fisher DA, et al. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence. Cancer Causes Control. 2010;21(9):1357–68.PubMedCrossRef
27.
Zurück zum Zitat US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137(2):129–31. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137(2):129–31.
28.
Zurück zum Zitat Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1232–5.PubMedCrossRef Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1232–5.PubMedCrossRef
29.
Zurück zum Zitat Fisher DA, Galanko J, Dudley TK, Shaheen NJ. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol. 2007;5(8):991–6.PubMedCrossRef Fisher DA, Galanko J, Dudley TK, Shaheen NJ. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol. 2007;5(8):991–6.PubMedCrossRef
30.
Zurück zum Zitat Stefos T, LaVellee N, Holden F. Fairness in prospective payment: a clustering approach. Health Serv Res. 1992;27(2):239–61.PubMed Stefos T, LaVellee N, Holden F. Fairness in prospective payment: a clustering approach. Health Serv Res. 1992;27(2):239–61.PubMed
31.
Zurück zum Zitat Szabo CR. 2005 Facility Complexity Model. Veterans Health Administration. Washington: NLB Human Resources Committee; 2005. Szabo CR. 2005 Facility Complexity Model. Veterans Health Administration. Washington: NLB Human Resources Committee; 2005.
32.
Zurück zum Zitat Yano EM, Soban LM, Parkerton PH, Etzioni DA. Primary care practice organization influences colorectal cancer screening performance. Health Serv Res. 2007;42(3 Pt 1):1130–49.PubMedCrossRef Yano EM, Soban LM, Parkerton PH, Etzioni DA. Primary care practice organization influences colorectal cancer screening performance. Health Serv Res. 2007;42(3 Pt 1):1130–49.PubMedCrossRef
33.
Zurück zum Zitat Burgess DJ, van Ryn M, Grill J, Noorbaloochi S, Griffin JM, Ricards J, et al. Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med. 2011;26(3):251–8.PubMedCrossRef Burgess DJ, van Ryn M, Grill J, Noorbaloochi S, Griffin JM, Ricards J, et al. Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med. 2011;26(3):251–8.PubMedCrossRef
34.
Zurück zum Zitat Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2nd ed. New York: John Wiley; 2003. Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2nd ed. New York: John Wiley; 2003.
35.
Zurück zum Zitat Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: Wiley; 1987.CrossRef Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: Wiley; 1987.CrossRef
36.
Zurück zum Zitat Hahn DL. The delivery of clinical preventive services: acute care intervention. J Fam Pract. 1999;48(10):785–9.PubMed Hahn DL. The delivery of clinical preventive services: acute care intervention. J Fam Pract. 1999;48(10):785–9.PubMed
37.
Zurück zum Zitat Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082–91.PubMedCrossRef Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082–91.PubMedCrossRef
38.
Zurück zum Zitat Kodl MM, Powell AA, Noorbaloochi S, Grill JP, Bangerter AK, Partin MR. Mental health, frequency of healthcare visits, and colorectal cancer screening. Med Care. 2010;48(10):934–9.PubMedCrossRef Kodl MM, Powell AA, Noorbaloochi S, Grill JP, Bangerter AK, Partin MR. Mental health, frequency of healthcare visits, and colorectal cancer screening. Med Care. 2010;48(10):934–9.PubMedCrossRef
39.
Zurück zum Zitat Ruffin MT, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract. 2000;13(1):1–10.PubMed Ruffin MT, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract. 2000;13(1):1–10.PubMed
40.
Zurück zum Zitat Zimmerman RK, Nowalk MP, Tabbarah M, Grufferman S. Predictors of colorectal cancer screening in diverse primary care practices. BMC Health Serv Res. 2006;6:116.PubMedCrossRef Zimmerman RK, Nowalk MP, Tabbarah M, Grufferman S. Predictors of colorectal cancer screening in diverse primary care practices. BMC Health Serv Res. 2006;6:116.PubMedCrossRef
41.
Zurück zum Zitat Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234–40.PubMedCrossRef Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234–40.PubMedCrossRef
42.
Zurück zum Zitat Chao HH, Schwartz AR, Hersh J, Hunnibell L, Jackson GL, Provenzale DT, et al. Improving colorectal cancer screening and care in the Veterans Affairs Healthcare system. Clin Colorectal Cancer. 2009;8(1):22–8.PubMedCrossRef Chao HH, Schwartz AR, Hersh J, Hunnibell L, Jackson GL, Provenzale DT, et al. Improving colorectal cancer screening and care in the Veterans Affairs Healthcare system. Clin Colorectal Cancer. 2009;8(1):22–8.PubMedCrossRef
43.
Zurück zum Zitat Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006–2007. Am J Prev Med. 2009;37(1):8–16.PubMedCrossRef Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006–2007. Am J Prev Med. 2009;37(1):8–16.PubMedCrossRef
44.
Zurück zum Zitat Shah TU, McNeil R, Wu R, Fisher DA. Understanding gastroenterologist adherence to polyp surveillance guidelines. Am J Gastroenterol. In press. Shah TU, McNeil R, Wu R, Fisher DA. Understanding gastroenterologist adherence to polyp surveillance guidelines. Am J Gastroenterol. In press.
45.
Zurück zum Zitat Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33(1):88–100.PubMedCrossRef Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33(1):88–100.PubMedCrossRef
46.
Zurück zum Zitat Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668–76.PubMed Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668–76.PubMed
47.
Zurück zum Zitat Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, et al. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev. 2008;17(4):768–76.PubMedCrossRef Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, et al. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev. 2008;17(4):768–76.PubMedCrossRef
Metadaten
Titel
Levels and Variation in Overuse of Fecal Occult Blood Testing in the Veterans Health Administration
verfasst von
Melissa R. Partin, PhD
Adam A. Powell, PhD
Ann Bangerter, BS
Krysten Halek, MA
James F. Burgess Jr, PhD
Deborah A. Fisher, MD
David B. Nelson, PhD
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 12/2012
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-012-2163-9

Weitere Artikel der Ausgabe 12/2012

Journal of General Internal Medicine 12/2012 Zur Ausgabe

Clinical Practice: Clinical Images

Gemcitabine Associated Pseudocellulitis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.